创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

CHEN Saihua, MAIMAITI Munire, ZHONG Ziwei, HONG Ze, WANG Chen. Progress of Research on Stimulator of Interferon Genes-Associated Vasculopathy with Onset in Infancy[J]. Progress in Pharmaceutical Sciences, 2025, 49(2): 137-145. DOI: 10.20053/j.issn1001-5094.2025.02.006
Citation: CHEN Saihua, MAIMAITI Munire, ZHONG Ziwei, HONG Ze, WANG Chen. Progress of Research on Stimulator of Interferon Genes-Associated Vasculopathy with Onset in Infancy[J]. Progress in Pharmaceutical Sciences, 2025, 49(2): 137-145. DOI: 10.20053/j.issn1001-5094.2025.02.006

Progress of Research on Stimulator of Interferon Genes-Associated Vasculopathy with Onset in Infancy

  • Stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy (SAVI) is a rare auto-inflammatory disease caused by gain-of-function mutations in human STING1 gene. With the increasing number of SAVI patients reported in recent years and the establishment of related mouse disease models, researchers have gradually deepened their understanding of the pathogenesis and treatment strategies of SAVI. This paper systematically reviews the reported cases of SAVI to briefly describe their pathological mechanisms and treatment strategies, with a view to providing some reference for the clinical treatment of this rare disease.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return